SCHEMBL6510337

SCHEMBL6510337

C#CCCOS(=O)(=O)c1ccccc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
GAA P10253 2/20 0.38
POLB P06746 1/20 0.38
ALDH1A1 P00352 5/20 0.37
ATM Q13315 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
RAPGEF4 Q8WZA2 1/20 0.35
RXFP1 Q9HBX9 1/20 0.33
HTR6 P50406 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8654494 0.84 KMT2A (0.45) L3MBTL1KMT2AMEN1ESR1ESR2
SCHEMBL8756138 0.83 L3MBTL1 (0.49) CA2CA9L3MBTL1KMT2AMEN1
SCHEMBL7619544 0.81 KMT2A (0.43) L3MBTL1KMT2AMEN1ESR1ESR2
SCHEMBL19280308 0.81 CA2 (0.42) CA2CA9KMT2AMEN1NFE2L2
SCHEMBL6411427 0.80 KMT2A (0.42) CA2L3MBTL1KMT2AMEN1ESR1
SCHEMBL3620171 0.78 KMT2A (0.41) CA2L3MBTL1KMT2AMEN1ESR1
SCHEMBL71839 0.78 KMT2A (0.41) L3MBTL1KMT2AMEN1ESR1ESR2
SCHEMBL8746193 0.78 GAA (0.48) L3MBTL1KMT2AMEN1ESR1ESR2
Hydrochloric Acid SCHEMBL27691765 0.78 KMT2A (0.41) CA2L3MBTL1KMT2AMEN1ESR1
SCHEMBL2762565 0.78 KMT2A (0.41) L3MBTL1KMT2AMEN1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240252657-A1 HEMTAC SMALL-MOLECULE DEGRADATION AGENT AND APPLICATION THEREOF SHANDONG UNIVERSITY (CN) 2024-08-01 US disclosed
EP-4306528-A1 HEMTAC SMALL MOLECULE DEGRADATION AGENT AND USE THEREOF Shandong University (CN) 2024-01-17 EP disclosed
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors ELI LILLY AND COMPANY 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240252657-A1 HEMTAC SMALL-MOLECULE DEGRADATION AGENT AND APPLICATION THEREOF HSP90AB1, HSP90AA1, HSP90AB2P CA2 3554/4885CA9 4071/4885L3MBTL1 1612/4885
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors NCOA4, PPARG, PPARA CA2 2411/4885CA9 2750/4885L3MBTL1 3898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.